Document is current

Any future updates will be listed below

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-592

Published Online: 2014-08-15

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark